New grant for CFTR research from the Dutch Patient organization (NCFS)
Ineke Braakman receives €50,000 from the Dutch Cystic Fibrosis Patient organization (NCFS) to research the effect of intragenic modifiers on CFTR biosynthesis. Although CF is caused by a defect in only a single gene, CF patients with the same mutation in CFTR show significant variation in disease progression and response to therapy, such as the … Read more